Novanta Inc. NOVT
Nov 4, 2026, 2:10 PM EST
- YTD
- +20.88%
- 1 year
- +11.21%
- Market cap
- 5.44B
- Revenue (ttm)
- 1.03B
- Profit margin
- 6.00%
- EPS (ttm)
- 1.58
- Shares out
- 37.82M
- P/E ratio
- 91.06
- Forward P/E
- 33.78
- YTD return
- +20.88%
- 1-year return
- +11.21%
- Volume
- 172.79K
- Avg volume
- 395.61K
- Open
- 150.08
- Previous close
- 147.49
- Day's range
- 140.30 – 150.08
- 52-week range
- 98.27 – 176.38
- Beta
- 1.70
- Price target
- 194.50 (+35.2%)
- Earnings date
- Nov 9, 2026
2Y -30.66 (-17.60%)
Key statistics
- Enterprise value
- 5.10B
- PEG ratio
- 0.00
- Price / sales
- 5.42
- Price / book
- 3.45
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 10.30%
- Free cash flow
- 118.38M
- Total cash
- 718.65M
- Total debt
- 285.60M
- Return on equity
- 5.11%
- Short % of float
- 15.92%
- 50-day average
- 142.34
- 200-day average
- 142.37
Analyst view
- Target (low)
- 194.00
- Target (mean)
- 194.50
- Target (high)
- 195.00
- Strong buy1
- Buy2
- Hold0
- Sell0
- Strong sell0
Next earnings
Nov 9, 2026
Expected Nov 9, 2026. Consensus EPS estimate 0.96667.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 9, 2026 | Oct 3, 2026 | 0.967 | — | — | — |
| Aug 5, 2026 | Jul 3, 2026 | 0.83 | 0.89 | +0.06 | +7.23% |
| May 11, 2026 | Apr 3, 2026 | 0.78 | 0.81 | +0.03 | +3.85% |
| Feb 23, 2026 | Dec 31, 2025 | 0.88 | 0.91 | +0.03 | +3.41% |
| Nov 3, 2025 | Sep 26, 2025 | 0.81 | 0.87 | +0.06 | +7.41% |
| Aug 5, 2025 | Jun 27, 2025 | 0.74 | 0.76 | +0.02 | +2.70% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 13, 2026 | Baird | main | Outperform | Outperform |
| Mar 30, 2026 | Baird | up | Neutral | Outperform |
| Aug 11, 2025 | Baird | main | Neutral | Neutral |
| Mar 3, 2025 | Baird | main | Neutral | Neutral |
| Nov 6, 2024 | Baird | main | Neutral | Neutral |
| Aug 7, 2024 | Baird | main | Neutral | Neutral |
About Novanta Inc.
Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. The company operates Automation Enabling Technologies and Medical Solutions segments. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam steering and scanning solutions, laser sources, robotic and precision motion, robotic end-of-arm tooling, and bearing spindles. This segment serves advanced industrial processes, advanced industrial and medical robotics, other medical and life science automation applications, and medical laser procedures, such as ophthalmology applications. The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; imaging, identification and RFID solutions; advanced motion control solutions; and light engines, and integrated operating room technologies. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was incorporated in 1968 and is based in Bedford, Massachusetts.
- Sector
- Technology
- Industry
- Scientific & Technical Instruments
- Country
- United States
- Website
- novanta.com
News
Baron Discovery Fund Q3 2026 Portfolio Activity 
Human Data, Robot Hands: Where Automation Goes Next 
Novanta to Present at the Baird 2026 Global Industrial Conference on Wednesday, November 11, 2026 
Novanta to Present at the Baird 2026 Global Industrial Conference on Wednesday, November 11, 2026 
How to Invest in AI Drug Discovery 
Novanta Inc. Announces Schedule of Third Quarter 2026 Earnings Release and Conference Call 
Here's How Much $100 Invested In Novanta 15 Years Ago Would Be Worth Today 
Eltek (NASDAQ:ELTK) vs. Novanta (NASDAQ:NOVT) Financial Survey 
Here’s How Much You Would Have Made Owning Novanta Stock In The Last 15 Years 
Analyzing Senstar Technologies (NASDAQ:SNT) and Novanta (NASDAQ:NOVT)
Your note
Sign in to keep a note on NOVT — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BUCKLEY ROBERT J | Chief Financial Officer | Sale | Mar 15, 2026 | 132,835 |
| BURKE JOHN JOSEPH II | Officer | Conversion of Exercise of derivative security | Feb 23, 2026 | 8,900 |
| CARPENTER LONNY J | Director | Conversion of Exercise of derivative security | Jan 1, 2026 | 5,848 |
| GLASTRA MATTHIJS | Chief Executive Officer | Sale | Jul 1, 2026 | 84,143 |
| HULIT BARBARA B | Director | Conversion of Exercise of derivative security | Jan 1, 2025 | 2,146 |
| JOHNSON ROBERT MATTHEW | Director | Conversion of Exercise of derivative security | Jan 1, 2026 | 2,143 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 12.69% | 4,798,035 | 707.66M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 6.33% | 2,395,681 | 353.34M | Jun 29, 2026 |
| Price (T.Rowe) Associates Inc | 5.88% | 2,222,445 | 327.79M | Jun 29, 2026 |
| Allspring Global Investments Holdings, LLC | 4.81% | 1,817,594 | 268.08M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.25% | 1,606,928 | 237.01M | Jun 29, 2026 |
| State Street Corporation | 3.80% | 1,436,785 | 211.91M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Mid-Cap ETF | 3.56% | 1,347,475 | 198.74M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.00% | 1,132,818 | 167.08M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.48% | 938,518 | 138.42M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.16% | 817,033 | 120.50M | Jun 29, 2026 |
| VANGUARD WORLD FUND-Vanguard Information Technology Index Fund | 2.02% | 762,666 | 112.49M | Aug 30, 2026 |
| T. Rowe Price Mid-Cap Value Fund, Inc. | 2.01% | 759,889 | 112.08M | Jun 29, 2026 |